The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Condition: Schizophrenia Intervention: Drug: Lurasidone Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
Conditions: Nausea; Vomiting; Head and Neck Squamous Cell Carcinoma; Radiotherapy Side Effect Intervention: Drug: Olanzapine Sponsor: Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials